Abbott Laboratories faces a criminal investigation by the Justice Department, after its recall of formulas due to complaints of bacterial infections exacerbated a shortage that began due to pandemic-induced supply chain issues.
The Justice Department was investigating conduct at Abbott’s plant in Sturgis, Michigan,
According to an Abbott spokesman, they are fully cooperating with the Justice Department without specifying what aspect of the company is under scrutiny.
In February 2022, Abbott, the biggest US supplier of baby formula, recalled Similac and other infant formula products produced at its Michigan facility after reports of bacterial infections in babies who had consumed products made there.
The US Food and Drug Administration found "shocking" results during an inspection, such as cracks in vital equipment, inadequate hand-washing, and evidence of previous bacterial contamination.
The plant has since reopened.


Dollar Rises as Middle East Conflict Fuels Inflation and Rate Hike Fears
TSMC Q2 Revenue Surges 36% as AI Chip Demand Powers Growth Ahead of Earnings
NIH Infectious Disease Leadership Shake-Up Raises Concerns Amid Ebola, Hantavirus Outbreaks
South Korea Central Bank Set to Raise Interest Rates as Inflation Stays Elevated
US-Iran Strikes Escalate as Strait of Hormuz Crisis Pushes Oil Prices Higher
Deutsche Bank Fined A$2 Million by ASIC Over OTC Derivatives Reporting Errors
DOJ Seeks Dismissal of Gautam Adani Bribery Case, Citing Foreign Scope
SK Hynix Soars 13% in Nasdaq Debut After Record $26.5 Billion IPO
New Mexico AG Accuses DOJ of Delaying Jeffrey Epstein Ranch Investigation
Apple Sues OpenAI, Former Employees Over Alleged Trade Secret Theft
DOJ Subpoenas New York Times Journalists Over Air Force One Leak Report
BOJ May Raise Japan Growth Forecast While Keeping Focus on Inflation Risks
Gordie Howe Bridge to Open July 27 After U.S.-Canada Reach Toll Revenue Agreement
Yaskawa Electric Shares Slide as Weak Profit Overshadows Strong AI Demand
Takeda Hit With $885M Verdict Over Amitiza Generic Drug Delay Scheme
Levi Strauss Raises 2026 Outlook After Q2 Earnings Beat, Shares Drop Despite Strong Results
RFK Jr. Spokesman Resigns Over Trump Administration’s Flavored E-Cigarette Policy 



